Teladoc health, inc. (TDOC)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15
Cash flows used in operating activities:
Net loss

-29,603

-19,044

-20,346

-29,324

-30,150

-24,879

-23,264

-25,079

-23,862

-44,383

-31,330

-15,415

-15,654

-14,261

-29,772

-14,879

-15,304

-15,007

-13,246

-17,064

-12,703

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization

11,228

11,092

11,417

10,880

11,563

9,557

9,746

8,046

8,253

7,402

6,418

2,668

2,607

2,597

2,607

1,558

1,508

1,546

1,491

923

903

Allowance for doubtful accounts

1,247

948

703

231

783

708

277

110

1,148

388

579

458

306

442

541

652

777

616

460

507

451

Stock-based compensation

18,315

18,457

17,354

17,368

13,523

12,683

12,195

11,059

7,832

16,969

5,966

4,565

3,097

2,525

2,276

1,634

1,288

979

718

567

811

Deferred income taxes

-2,820

-580

-8,816

1,200

-2,672

-340

-649

-673

-585

-531

-74

149

150

150

188

10

162

161

162

171

-458

Accretion of interest

6,859

6,016

7,075

6,287

6,060

5,894

5,966

4,609

3,018

3,120

3,234

46

-18

233

-146

46

129

219

160

42

39

Changes in operating assets and liabilities:
Accounts receivable

17,219

3,498

5,149

-1,014

8,251

3,396

3,508

-711

4,738

473

2,000

-623

1,809

1,385

-989

42

2,462

3,380

776

358

2,281

Due from officer

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-253

Prepaid expenses and other current assets

-101

466

3,470

-901

-350

956

1,116

1,139

-599

-714

3,417

-1,130

430

-290

1,551

-978

543

-363

1,215

-1,488

1,593

Other assets

-137

178

1

-44

-30

87

254

104

-31

-187

196

-116

9

-

-

-

-

8

19

-20

-12

Accounts payable

-502

2,881

-2,350

402

-28

-34

-1,728

1,904

-533

2,316

303

-798

-287

1,452

-558

-572

-1,135

157

-4,517

2,391

1,357

Accrued expenses and other current liabilities

21,565

-6,171

10,654

-4,172

14,530

-3,568

7,848

-2,123

1,836

-5,140

7,729

737

966

-1,839

1,186

-2,936

1,288

2,857

-3,466

591

3,475

Accrued compensation

-13,798

6,359

7,320

2,604

-11,737

6,489

5,803

4,105

-7,917

2,801

1,231

1,657

-1,921

1,665

1,718

1,549

-3,244

371

868

2,318

-670

Operating lease liabilities

-1,287

-936

-687

-315

-479

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other liabilities

-543

3,242

-214

-971

-1,414

405

295

-1,002

1,047

-

-

1,150

495

621

-596

263

353

-2,476

2,598

1,398

68

Net cash used in operating activities

-6,320

18,122

13,490

6,149

-7,892

2,476

10,181

-3,646

-13,871

-7,275

-11,745

-2,914

-12,507

-7,534

-15,407

-11,751

-17,183

-12,804

-16,782

-7,259

-10,336

Cash flows provided by (used in) investing activities:
Purchase of property and equipment

962

663

1,599

677

571

1,279

717

1,458

557

590

744

679

620

990

340

503

275

794

2,015

3,101

365

Purchase of internal-use software

1,966

2,732

1,683

1,876

1,099

1,638

1,370

917

471

1,409

1,188

133

152

452

194

273

385

368

325

415

434

Purchase of marketable securities

-

-

-

-

-

-

-

-

-

29,591

84,716

-3

34,957

-41

-1

7,066

37,122

-

-

-

-

Proceeds from marketable securities

0

12,935

16,470

13,695

9,000

4,700

11,500

42,970

25,000

39,933

26,143

4,937

14,740

15,113

25,855

19,893

49,856

-

-

-

-

Sale of assets

0

-10

3

1

6

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquisition of business, net of cash acquired

9,000

-17

-3

11,207

0

-

-

-

-

-

-

-

-

-

-

-

-

0

4,222

10,276

3,269

Net cash (used in) provided by investing activities

-11,928

9,547

13,194

-5,064

7,336

-42,348

461

-239,581

23,972

8,342

-439,860

4,128

-20,989

13,712

-11,691

12,051

12,074

14,266

-104,609

-13,792

-4,068

Cash flows provided by financing activities:
Net proceeds from the exercise of stock options

14,889

8,463

9,119

6,847

8,854

5,124

10,433

7,122

8,643

3,841

2,680

3,121

1,195

315

1,619

94

496

102

65

233

28

Repayment of debt

-

-

-

-

-

-

-

-

-

180,249

44,191

0

2,000

5,499

11,042

312

313

-

-

-

-

Proceeds from issuance of common stock

-

-

-

-

-

-

-

-

-

134,626

0

0

123,928

-

-

-

-

-

-

-

-

Cash received for withholding taxes on stock-based compensation, net

164

73

244

-3,734

1,848

1,182

39

-3,055

3,555

-569

235

-46

306

-511

532

6

53

-

-

-

-

Net cash provided by financing activities

15,053

10,041

9,153

5,198

10,702

7,449

341,349

284,616

12,198

-41,463

125,403

268,062

123,429

-195

15,349

5,288

236

-460

160,032

4,414

28

Net (decrease) increase in cash and cash equivalents

-3,195

37,710

35,837

6,283

10,146

-32,423

351,991

41,389

22,299

-40,396

-326,202

269,276

89,933

5,983

-11,749

5,588

-4,873

1,002

38,641

-16,637

-14,376

Foreign exchange difference

-3,202

1,401

-1,038

202

-177

-1,142

-241

-764

63

-

-

-

-

-

-

-

-

-

-

-

-

Income taxes paid

0

464

537

286

23

203

179

7

52

-

-

-

994

-

-

-

-

-

-

-

-

Interest paid

0

6,112

10

6,102

0

6,178

0

4,123

2

4,723

2,880

-540

2,387

653

684

446

604

627

448

496

424